XML 53 R42.htm IDEA: XBRL DOCUMENT v3.26.1
STOCK CAPITAL (Tables)
3 Months Ended
Mar. 31, 2026
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of activity in the share options granted to employees and members of board of directors
   
Number of options
   
Weighted average
exercise price
   
Weighted average remaining contractual term in years
   
Aggregate intrinsic Value
 
Outstanding as of December 31, 2025
   
191,187
   
$
49.37
     
1.40
   
$
950
 
Exercised
   
(141,584
)
   
27.20
     
-
     
1,769
 
Forfeited or expired
   
(7,929
)
   
150.09
     
-
     
-
 
Outstanding as of March 31, 2026
   
41,674
   
$
105.54
     
2.14
   
$
441
 
Vested and expected to vest as of March 31, 2026
   
41,674
   
$
105.54
     
2.15
   
$
441
 
Exercisable as of March 31, 2026
   
41,674
   
$
105.54
     
2.15
   
$
441
 
Schedule of RSU activity
   
RSU
   
PSU
 
   
Number of
Shares
Outstanding
   
Weighted average grant date fair value
   
Number of
Shares
Outstanding
   
Weighted average grant date fair value
 
Unvested as of December 31, 2025
   
3,824,774
   
$
34.02
     
841,487
   
$
14.00
 
Granted
   
396,183
     
34.95
     
618,169
     
37.76
 
Vested
   
(316,192
)
   
48.57
     
-
     
-
 
Forfeited
   
(136,123
)
   
48.12
     
(21,201
)
   
212.91
 
Unvested as of March 31, 2026
   
3,768,642
   
$
32.38
     
1,438,455
   
$
21.28
 
Schedule of recognized stock-based compensation expenses
   
Three Months Ended
March 31,
 
   
2026
   
2025
 
Stock-based compensation expenses:
           
Cost of revenues
 
$
3,607
   
$
4,372
 
Research and development, net
   
8,061
     
15,911
 
Selling and marketing
   
4,151
     
4,742
 
General and administrative
   
4,033
     
6,401
 
Total stock-based compensation expenses
 
$
19,852
   
$
31,426
 
                 
Stock-based compensation capitalized:
               
Inventory
 
$
320
   
$
646
 
Other long-term assets
   
-
     
439
 
Total stock-based compensation capitalized
 
$
320
   
$
1,085